Effects of nintedanib in patients with idiopathic pulmonary fibrosis by GAP stage

Christopher J. Ryerson, Martin Kolb, Luca Richeldi, Joyce Lee, Daniel Wachtlin, Susanne Stowasser, Venerino Poletti

Source: ERJ Open Res, 5 (2) 00127-2018; 10.1183/23120541.00127-2018
Journal Issue: April
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Christopher J. Ryerson, Martin Kolb, Luca Richeldi, Joyce Lee, Daniel Wachtlin, Susanne Stowasser, Venerino Poletti. Effects of nintedanib in patients with idiopathic pulmonary fibrosis by GAP stage. ERJ Open Res, 5 (2) 00127-2018; 10.1183/23120541.00127-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: